NCT01747616View on ClinicalTrials.gov

Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2012

Conditions
Dry Eye Syndrome
Interventions
DEVICE

Chitosan-N-acetylcysteine eye drops (concentration of 0.1%)

1 drop of the medical device in 1 randomly chosen eye

OTHER

Physiological saline solution

1 drop as placebo in the other eye not receiving the medical device

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

Sponsors

Collaborators (1)

Croma-Pharma GmbH
All Listed Sponsors
collaborator

Croma-Pharma GmbH

INDUSTRY

lead

Medical University of Vienna

OTHER

NCT01747616 - Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses | Biotech Hunter | Biotech Hunter